The latest updates on Longhorn. News Van Agens 4/11/24 Van Agens 4/11/24 Longhorn Vaccines and Diagnostics to Present Data on LHNVD-105, a Universal Vaccine Candidate, at ECCMID 2024 Read More Van Agens 4/2/24 Van Agens 4/2/24 Longhorn Vaccines and Diagnostics Presents at World Vaccine Congress on Advantages of Single Peptide Vaccine for Broad Coverage of Human and Avian Influenza Viruses Read More Kyle Kostesich 11/15/23 Kyle Kostesich 11/15/23 Longhorn Vaccines and Diagnostics Presents Targeted Vaccine Approach for Mycobacterium Tuberculosis with LHNVD-301 Read More Kyle Kostesich 11/2/23 Kyle Kostesich 11/2/23 Longhorn Vaccines and Diagnostics to Present Data on Mycobacterium Tuberculosis Vaccine Candidate, LHNVD-301, at The Union World Conference on Lung Health 2023 Read More Kyle Kostesich 10/16/23 Kyle Kostesich 10/16/23 Longhorn Vaccines and Diagnostics Presents Data Demonstrating Durability of LHNVD-105 Universal Influenza Vaccine in Animal Models at IDWeek 2023 Read More Kyle Kostesich 10/12/23 Kyle Kostesich 10/12/23 Longhorn Vaccines and Diagnostics Announces Data Showing PrimeStore® Molecular Transport Medium Inactivates High Consequence Animal Viruses Read More Kyle Kostesich 10/3/23 Kyle Kostesich 10/3/23 Longhorn Vaccines and Diagnostics to Present Durability Data of Universal Influenza Vaccine, LHNVD-105, at IDWeek 2023 Read More Kyle Kostesich 9/27/23 Kyle Kostesich 9/27/23 New Study Shows Longhorn Vaccines and Diagnostics’ Universal Influenza Vaccine, LHNVD-105, Generates Broad and Durable Immune Responses in Animal Models Read More Kyle Kostesich 9/25/23 Kyle Kostesich 9/25/23 Longhorn Vaccines and Diagnostics Presents Data Demonstrating Neutralizing Activity of LHNVD-201 for Covid-19 and Influenza Co-Infections Read More Kyle Kostesich 9/19/23 Kyle Kostesich 9/19/23 Longhorn Vaccines and Diagnostics to Present Durability Data of Peptide-Based Vaccine LHNVD-201 for Covid-19 and Influenza Co-Infections at 17th Vaccine Congress Read More Kyle Kostesich 8/23/23 Kyle Kostesich 8/23/23 New Study Shows Longhorn Vaccines and Diagnostics’ PrimeStore Molecular Transport Medium Improves Tuberculosis Testing in Children Read More Media Coverage Guest User 12/19/22 Media Coverage Guest User 12/19/22 9 BioHealth Capital Region Companies That Are Developing Innovative Vaccines and Therapeutics to Combat Global Health Threats Read More Media Coverage Guest User 11/14/22 Media Coverage Guest User 11/14/22 Longhorn recognized as "Diagnostics Company of the Year" Read More Press Release Guest User 11/3/22 Press Release Guest User 11/3/22 Longhorn Vaccines & Diagnostics Recognized as BioTech Breakthrough’s “Diagnostics Company of the Year” Read More Press Release Guest User 10/19/22 Press Release Guest User 10/19/22 Longhorn Vaccines and Diagnostics to Present at Infectious Disease Week 2022 Read More Media Coverage Guest User 9/22/22 Media Coverage Guest User 9/22/22 Are we ready for an FAD together? Read More Press Release Guest User 9/19/22 Press Release Guest User 9/19/22 Longhorn Vaccines and Diagnostics to Present at The Allen D. Leman Swine Conference Read More Media Coverage Guest User 9/14/22 Media Coverage Guest User 9/14/22 Longhorn Vaccines and Diagnostics appoints Silver as senior VP Read More Press Release Guest User 9/8/22 Press Release Guest User 9/8/22 Longhorn Vaccines and Diagnostics Appoints Zoe Silver as Senior Vice President of Genomics & Diagnostics Read More Media Coverage Guest User 9/6/22 Media Coverage Guest User 9/6/22 Entrepreneurs: Jeff Fischer Read More Older Posts
Van Agens 4/11/24 Van Agens 4/11/24 Longhorn Vaccines and Diagnostics to Present Data on LHNVD-105, a Universal Vaccine Candidate, at ECCMID 2024 Read More
Van Agens 4/2/24 Van Agens 4/2/24 Longhorn Vaccines and Diagnostics Presents at World Vaccine Congress on Advantages of Single Peptide Vaccine for Broad Coverage of Human and Avian Influenza Viruses Read More
Kyle Kostesich 11/15/23 Kyle Kostesich 11/15/23 Longhorn Vaccines and Diagnostics Presents Targeted Vaccine Approach for Mycobacterium Tuberculosis with LHNVD-301 Read More
Kyle Kostesich 11/2/23 Kyle Kostesich 11/2/23 Longhorn Vaccines and Diagnostics to Present Data on Mycobacterium Tuberculosis Vaccine Candidate, LHNVD-301, at The Union World Conference on Lung Health 2023 Read More
Kyle Kostesich 10/16/23 Kyle Kostesich 10/16/23 Longhorn Vaccines and Diagnostics Presents Data Demonstrating Durability of LHNVD-105 Universal Influenza Vaccine in Animal Models at IDWeek 2023 Read More
Kyle Kostesich 10/12/23 Kyle Kostesich 10/12/23 Longhorn Vaccines and Diagnostics Announces Data Showing PrimeStore® Molecular Transport Medium Inactivates High Consequence Animal Viruses Read More
Kyle Kostesich 10/3/23 Kyle Kostesich 10/3/23 Longhorn Vaccines and Diagnostics to Present Durability Data of Universal Influenza Vaccine, LHNVD-105, at IDWeek 2023 Read More
Kyle Kostesich 9/27/23 Kyle Kostesich 9/27/23 New Study Shows Longhorn Vaccines and Diagnostics’ Universal Influenza Vaccine, LHNVD-105, Generates Broad and Durable Immune Responses in Animal Models Read More
Kyle Kostesich 9/25/23 Kyle Kostesich 9/25/23 Longhorn Vaccines and Diagnostics Presents Data Demonstrating Neutralizing Activity of LHNVD-201 for Covid-19 and Influenza Co-Infections Read More
Kyle Kostesich 9/19/23 Kyle Kostesich 9/19/23 Longhorn Vaccines and Diagnostics to Present Durability Data of Peptide-Based Vaccine LHNVD-201 for Covid-19 and Influenza Co-Infections at 17th Vaccine Congress Read More
Kyle Kostesich 8/23/23 Kyle Kostesich 8/23/23 New Study Shows Longhorn Vaccines and Diagnostics’ PrimeStore Molecular Transport Medium Improves Tuberculosis Testing in Children Read More
Media Coverage Guest User 12/19/22 Media Coverage Guest User 12/19/22 9 BioHealth Capital Region Companies That Are Developing Innovative Vaccines and Therapeutics to Combat Global Health Threats Read More
Media Coverage Guest User 11/14/22 Media Coverage Guest User 11/14/22 Longhorn recognized as "Diagnostics Company of the Year" Read More
Press Release Guest User 11/3/22 Press Release Guest User 11/3/22 Longhorn Vaccines & Diagnostics Recognized as BioTech Breakthrough’s “Diagnostics Company of the Year” Read More
Press Release Guest User 10/19/22 Press Release Guest User 10/19/22 Longhorn Vaccines and Diagnostics to Present at Infectious Disease Week 2022 Read More
Media Coverage Guest User 9/22/22 Media Coverage Guest User 9/22/22 Are we ready for an FAD together? Read More
Press Release Guest User 9/19/22 Press Release Guest User 9/19/22 Longhorn Vaccines and Diagnostics to Present at The Allen D. Leman Swine Conference Read More
Media Coverage Guest User 9/14/22 Media Coverage Guest User 9/14/22 Longhorn Vaccines and Diagnostics appoints Silver as senior VP Read More
Press Release Guest User 9/8/22 Press Release Guest User 9/8/22 Longhorn Vaccines and Diagnostics Appoints Zoe Silver as Senior Vice President of Genomics & Diagnostics Read More
Media Coverage Guest User 9/6/22 Media Coverage Guest User 9/6/22 Entrepreneurs: Jeff Fischer Read More
